Table 5. cagA and clinical outcome.
Overt gastric disease | NUD | |||
cagA status | n | % | n | % |
cagA+ | 21 | 77.8 | 53 | 56.4 |
cagA− | 6 | 22.2 | 15 | 16.0 |
cagA+ & cagA − | 0 | 0 | 23 | 24.5 |
no amplification | 0 | 0 | 3 | 3.2 |
Total | 27 | 100 | 94 | 100 |
Overt gastric disease | NUD | |||
cagA status | n | % | n | % |
cagA+ | 21 | 77.8 | 53 | 56.4 |
cagA− | 6 | 22.2 | 15 | 16.0 |
cagA+ & cagA − | 0 | 0 | 23 | 24.5 |
no amplification | 0 | 0 | 3 | 3.2 |
Total | 27 | 100 | 94 | 100 |